Home › Employers › Tosoh Bioscience LLC
Tosoh Bioscience LLC: H-1B salaries and sponsorship
Tosoh Bioscience LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $93,977.
Does Tosoh Bioscience LLC sponsor H-1B visas?
Tosoh Bioscience LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 7, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Sr. QA Complaints Compliance Specialit | 1 | $93,434 |
| Applications Scientist - HPLC | 1 | $110,000 |
| Applications Scientist - GPC/SEC Instruments | 1 | $93,977 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $93,434 |
| FY2024 | 2 | $101,988 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Applications Scientist - GPC/SEC Instruments | $93,977 Level II | King of Prussia, PA | May 7, 2024 | Oct 1, 2024 | Certified |
| Applications Scientist - HPLC | $110,000 Level II | King of Prussia, PA | May 7, 2024 | Oct 1, 2024 | Certified |
| Sr. QA Complaints Compliance Specialit | $93,434–$105,000 Level III | Warsaw, IN | Mar 24, 2023 | Apr 15, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).